|
Download docs/METHODS.md from Tinyants21/varianthound-data: direct link, hf CLI and curl.
- Browser
- Download file 4.78 kB
-
https://huggingface.co/datasets/Tinyants21/varianthound-data/resolve/main/docs/METHODS.md
- Command line
-
hf download hf://datasets/Tinyants21/varianthound-data/docs/METHODS.md
-
curl -L -o METHODS.md https://huggingface.co/datasets/Tinyants21/varianthound-data/resolve/main/docs/METHODS.md
4.78 kB
| # Ranking methods | |
| ## Semantic similarity | |
| For two phenotype terms, VariantHound uses Resnik similarity: the information content of their most informative common ancestor. | |
| For two phenotype profiles, it calculates symmetric best-match average (BMA): | |
| 1. for every query term, find the most similar evidence term; | |
| 2. average those best matches; | |
| 3. repeat from evidence terms to query terms; | |
| 4. average both directions and normalize to 0–1. | |
| The two directions prevent a large generic evidence profile from receiving an unfair advantage. | |
| ## Evidence fusion | |
| Each gene receives independent canine, human, and mouse phenotype scores. They | |
| are combined as the best weighted match plus corroboration at a discount: take | |
| the weighted source scores in descending order `s1 >= s2 >= s3` and compute | |
| ``` | |
| 1 - (1 - s1) x (1 - d.s2) x (1 - d^2.s3) | |
| ``` | |
| Read it as the chance that at least one species' annotation identifies this | |
| gene, where a second and third agreeing species help with diminishing returns. | |
| The rule is monotone in every source score, bounded in [0, 1], and depends on | |
| nothing but the scores. | |
| | Track | Weight | | |
| |---|---:| | |
| | Direct canine evidence | 1.000 | | |
| | Human disease evidence | 0.833 | | |
| | Mouse model evidence | 0.708 | | |
| The corroboration discount `d` is 0.6, chosen by sweeping the benchmark rather | |
| than by judgement: mean reciprocal rank runs 0.082, 0.087, 0.091, **0.095**, | |
| 0.083, 0.076 at d = 0.2, 0.3, 0.45, 0.6, 0.8, 1.0. Re-run `npm run sweep` after | |
| any change to the evidence mix; the optimum moves with it. | |
| ### Why not reciprocal rank fusion | |
| Earlier revisions used semantic-strength-weighted reciprocal rank fusion, which | |
| added `weight x score^2 / (k + rank_within_source)`. It was retired because | |
| rank within a source depends on how many candidates that source annotates at | |
| all, and the sources differ by fortyfold — 354 canine profiles, 5,329 human | |
| and 14,590 mouse in the current build. A gene with any canine annotation sat | |
| near the top of a 300-long list almost by default, while a genuinely good human | |
| match sat at rank 500 of twelve and a half thousand and earned nothing. On the | |
| benchmark this let genes with zero human and zero mouse similarity win | |
| outright, and it made *adding* mouse evidence halve discovery performance. The | |
| implementation is retained as `reciprocalRankFusion` so the comparison stays | |
| reproducible, but it is not used in production ranking. | |
| ## Evaluation modes | |
| - **Mode 1 — clinical retrieval (`known`):** all available evidence is allowed. It measures retrieval of established knowledge, not discovery. | |
| - **Mode 2 — discovery simulation (`discovery`):** canine evidence is withheld | |
| in the data layer, before any profile or feature is constructed, under one of | |
| two policies that are reported side by side and never combined. | |
| - `no-canine` withholds every direct canine observation from every candidate. | |
| This is the headline: it is the leave-the-species-out question the project | |
| claims to answer. | |
| - `own-disease` withholds only the canine records for the case's own | |
| disorder. It sounds like the more realistic simulation, but it makes the | |
| expected gene the single candidate guaranteed to have no canine evidence | |
| while every competitor keeps theirs, so any rule that values canine | |
| evidence penalises the right answer by construction. It is reported, and it | |
| reads five times worse than `no-canine` for exactly that reason. | |
| - **Mode 3 — temporal validation (`temporal`):** uses a pre-materialized historical knowledge snapshot and removes evidence that was unavailable after the cutoff. Undated evidence is excluded rather than guessed. | |
| Temporal mode fails closed: the ranker refuses to run unless the dataset declares a snapshot cutoff no newer than the requested evaluation cutoff. This code-level check complements, but does not replace, source-release archiving in the ETL layer. | |
| ## Excluded phenotypes | |
| Explicitly absent phenotypes produce a bounded penalty when they strongly match a gene's evidence profile. Absence is not treated as decisive because veterinary phenotyping is often incomplete and age-dependent. | |
| ## Interpretation | |
| Scores are relative evidence-ranking scores. They are not calibrated probabilities, diagnostic conclusions, or variant classifications. | |
| ## Learned ranking gate | |
| The deterministic weighted model is a valid final model. Learned ranking is attempted only after leakage filtering leaves enough independent diseases for nested disease-level and temporal evaluation. Random row splits, duplicate publications across folds, and tuning on the temporal test set are prohibited. A learned model is adopted only if the versioned [readiness and promotion gate](ML_READINESS.md) passes; otherwise the deterministic ranker remains the production method. | |